Clinical Study of CAR-iNKT Cells in the Treatment of Relapsed/Refractory/High-risk B-cell Tumors

Clinical trial NCT04814004 · UNKNOWN

Trial details

NCT number: NCT04814004
Sponsor: Kai Lin Xu; Jun Nian Zheng
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia B-cell Lymphoma Chronic Lymphocytic Leukemia

Start date: 2021-03-19
Primary completion: 2023-04-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.